Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-039241

Director acquired 5,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

SEIDENBERG BETH C · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2017-06-08 Grant or award : show line 1 in the form +5,000 13,689 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-06-08 Grant or award : show line 2 in the form NonQualified Stock Option (Right to Buy) +21,500 21,500 D
Loading xslF345X03/doc4.xml…